Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249175
Max Phase: Preclinical
Molecular Formula: C26H37ClN2O
Molecular Weight: 374.57
Molecule Type: Small molecule
Associated Items:
ID: ALA3249175
Max Phase: Preclinical
Molecular Formula: C26H37ClN2O
Molecular Weight: 374.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.O.c1ccc([C@H]2c3ccccc3[C@@H]3CCN(CCCN4CCCCC4)C[C@H]23)cc1
Standard InChI: InChI=1S/C26H34N2.ClH.H2O/c1-3-10-21(11-4-1)26-24-13-6-5-12-22(24)23-14-19-28(20-25(23)26)18-9-17-27-15-7-2-8-16-27;;/h1,3-6,10-13,23,25-26H,2,7-9,14-20H2;1H;1H2/t23-,25-,26-;;/m0../s1
Standard InChI Key: CNFHLEYIVPROMZ-GEWPENGBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 374.57 | Molecular Weight (Monoisotopic): 374.2722 | AlogP: 5.11 | #Rotatable Bonds: 5 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.18 | CX LogP: 4.78 | CX LogD: 1.65 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.72 | Np Likeness Score: -0.35 |
1. Ellefson CR, Woo CM, Cusic JW.. (1978) Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives., 21 (4): [PMID:650662] [10.1021/jm00202a005] |
Source(1):